Sanifort Pharma SA
Sanifort Pharma reported total assets of 408,425 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jan 2026).
The score of Sanifort Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sanifort Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 28 Jan 2026
- Year ended 30 Jun 2024filed on 03 Feb 2025
- Year ended 30 Jun 2023filed on 31 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
Sanifort Pharma's financial analysis
- Solvency-880.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sanifort Pharma
Sanifort Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0882.765.326
- VAT number
- BE0882765326
- Peppol
- Registered · 0208:0882765326 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 24 Jul 2006
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 28 Jan 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Sanifort Pharma (SA) has been based in Leuven since 2006, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 75,588 € and equity of −€3.60m; its revenue is not published. Its solvency stands at -880.6%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sanifort Pharma
Companies in the same business, of comparable size and area, outside its group.
- Belipharm Wholesale of pharmaceutical and medical goods Leuven · balance sheet 449,785 €
- Vinterno Wholesale of pharmaceutical and medical goods Kalmthout · balance sheet 153,990 €
- Phytos Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 2,672 €
- CF Pharma Wholesale of pharmaceutical and medical goods Beaumont · balance sheet 469,314 €
- Biomedim Retail sale of pharmaceutical products Plombières · balance sheet 430,148 €
- 3Pharma Wholesale of pharmaceutical and medical goods Sint-Niklaas · balance sheet 307,833 €
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Dansaert APO Wholesale of pharmaceutical and medical goods Brussels · balance sheet 723,308 €
Frequently asked questions about Sanifort Pharma
What is the revenue of Sanifort Pharma?
Sanifort Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sanifort Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0882765326 for Sanifort Pharma, if the company is VAT-registered. Its company number (CBE) is 0882.765.326.
Where is the registered office of Sanifort Pharma?
According to the CBE register, the registered office of Sanifort Pharma is in 3001 Leuven.
What is the equity of Sanifort Pharma?
At the close of the 2025 financial year, the equity of Sanifort Pharma amounts to -3,596,722 €, a solvency of -880.6% of total assets.
Who manages Sanifort Pharma?
The register lists 3 active mandates at Sanifort Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sanifort Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →